Axsome Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapies for the management of pain and other central nervous system, or CNS, disorders.
| Website: | www.axsome.com |
| Main Phone: | +1 212 332-3241 |
| Address: | 25 Broadway |
| Address 2: | 9th Floor |
| State: | NY |
| City / Town: | New York |
| Country: | USA |
| Postal Code: | 10004 |
| Exchange: | NSC |
| Employees: | 11 |
| NAICS: | Pharmaceutical P |
| Last Price 2.65 | Change $ 0.10 | Change % 3.92 | Tick N/A |
| Bid 2.50 | Bid Size 4,000.00 | Ask 3.10 | Ask Size 900.00 |
| Open 2.55 | High 2.73 | Low 2.48 | Prev Close 2.55 |
| Last Trade | Volume 288,775 | 52 Wk Hi 6.45 | 52 Wk Low 2.05 |
| Market Cap 67.6 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 25,492,992.00 | EPS (TTM) -1.28 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 9 |
| Number of Buys | 0 | 9 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 590433 |
| Last 10 Buys | Shares |
|---|---|
| Randall E. Kaye | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 29 | 29 | 29 | 29 |
| Low Target Price Estimate | 13 | 13 | 13 | 13 |
| Mean Target Price Estimate | 23.33 | 23.33 | 23 | 23.33 |
| Standard Deviation | 8.96 | 8.96 | 8.72 | 8.96 |
| Date of Most Recent Estimate | 08/19/16 | 08/11/16 | 05/27/16 | 08/19/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2016-08-10 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 80 | 2016-08-09 |
| 10-Q/A | Amendment to a previously filed 10-Q | 82 | 2016-08-09 |
| 10-K/A | Amendment to a previously filed 10-K | 144 | 2016-08-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 34 | 2016-07-13 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-07-12 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-06-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-01 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-01 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-01 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
